✦ LIBER ✦

Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson’s disease patients

✍ Scribed by Thomas Müller; Wilfried Kuhn

Publisher: Springer
Year: 2006
Tongue: English
Weight: 97 KB
Volume: 62
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-006-0132-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of entacapone on plasma homocyste

Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients

✍ Martin Nevrly; Petr Kanovsky; Hana Vranova; Katerina Langova; Petr Hlustik 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 196 KB

Studies on homocysteine and dehydroepian

Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer’s disease patients and in Parkinson’s disease patients

✍ S. Genedani; G. Rasio; P. Cortelli; F. Antonelli; D. Guidolin; M. Galantucci; K. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 125 KB

Elevation of total homocysteine levels i

Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel

✍ Thomas Müller; Constanze Jugel; Reinhard Ehret; Georg Ebersbach; Gunar Bengel; S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 253 KB

Effects of levodopa and COMT inhibitors

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

✍ Paolo Lamberti; Stefano Zoccolella; Giovanni Iliceto; Elio Armenise; Angela Frad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). T

Modifications of plasma and platelet lev

Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson’s disease

✍ F. Blandini; G. Nappi; R. Fancellu; A. Mangiagalli; A. Samuele; G. Riboldazzi; D 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 336 KB

Evaluation of nitric oxide synthase acti

Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet’s disease

✍ Seyithan Taysi; Refik Ali Sari; Hakan Dursun; Adnan Yilmaz; Mustafa Keles; Kerim 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 130 KB